Pre-eclampsia primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
== Primary prevention == | == Primary prevention == | ||
*Effective measures for the primary prevention of [[preeclampsia ]] include administration of low dose [[aspirin]] before the 16th week of [[pregnancy]]. | *Effective measures for the primary prevention of [[preeclampsia ]] include administration of low dose [[aspirin]] before the 16th week of [[pregnancy]].<ref name="RolnikWright2017">{{cite journal|last1=Rolnik|first1=Daniel L.|last2=Wright|first2=David|last3=Poon|first3=Liona C.|last4=O’Gorman|first4=Neil|last5=Syngelaki|first5=Argyro|last6=de Paco Matallana|first6=Catalina|last7=Akolekar|first7=Ranjit|last8=Cicero|first8=Simona|last9=Janga|first9=Deepa|last10=Singh|first10=Mandeep|last11=Molina|first11=Francisca S.|last12=Persico|first12=Nicola|last13=Jani|first13=Jacques C.|last14=Plasencia|first14=Walter|last15=Papaioannou|first15=George|last16=Tenenbaum-Gavish|first16=Kinneret|last17=Meiri|first17=Hamutal|last18=Gizurarson|first18=Sveinbjorn|last19=Maclagan|first19=Kate|last20=Nicolaides|first20=Kypros H.|title=Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia|journal=New England Journal of Medicine|volume=377|issue=7|year=2017|pages=613–622|issn=0028-4793|doi=10.1056/NEJMoa1704559}}</ref> | ||
*In a recent clinical trial, there was 62% reduction in the occurrence of [[preeclampsia]] in patients received 150 mg aspirin daily. | *In a recent clinical trial, there was 62% reduction in the occurrence of [[preeclampsia]] in patients received 150 mg aspirin daily. | ||
Revision as of 11:04, 7 October 2020
|
Pre-eclampsia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pre-eclampsia primary prevention On the Web |
|
American Roentgen Ray Society Images of Pre-eclampsia primary prevention |
|
Risk calculators and risk factors for Pre-eclampsia primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]
Primary prevention
- Effective measures for the primary prevention of preeclampsia include administration of low dose aspirin before the 16th week of pregnancy.[1]
- In a recent clinical trial, there was 62% reduction in the occurrence of preeclampsia in patients received 150 mg aspirin daily.
References
- ↑ Rolnik, Daniel L.; Wright, David; Poon, Liona C.; O’Gorman, Neil; Syngelaki, Argyro; de Paco Matallana, Catalina; Akolekar, Ranjit; Cicero, Simona; Janga, Deepa; Singh, Mandeep; Molina, Francisca S.; Persico, Nicola; Jani, Jacques C.; Plasencia, Walter; Papaioannou, George; Tenenbaum-Gavish, Kinneret; Meiri, Hamutal; Gizurarson, Sveinbjorn; Maclagan, Kate; Nicolaides, Kypros H. (2017). "Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia". New England Journal of Medicine. 377 (7): 613–622. doi:10.1056/NEJMoa1704559. ISSN 0028-4793.